COVID-19: Singapore approves first bivalent vaccine

Singapore has approved its first bivalent COVID-19 vaccine that targets both the original virus strain and the Omicron variant. It is an updated version of the Moderna shot and the company says it is able to bring in “hundreds of thousands” of doses into Singapore by the end of the month.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia

You May Also Like